Stocks: In Insider Trading, GlaxoSmithKline Buys Shares of Theravance
Plus, Marubeni buys shares of Aircastle; Shutterfly and Jacob's Engineering Group see purchases.
A Closer Look at 4 Potential Blockbuster Drugs of 2014
Let’s take a closer look at what future sales of four potential blockbusters from Gilead Sciences, Johnson & Johnson, Pharmacylics, GlaxoSmithKline, and Theravance could mean for each of these companies in 2014.
Does Furiex Pharmaceuticals Inc Still Have Upside Potential?
Furiex shares have soared after reporting late-stage clinical trial results for its irritable bowel syndrome drug. Can it continue to head higher?